Virtus ETF Advisers LLC Idera Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

  • $206 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 05, 2019
SELL
$2.77 - $9.38 $95,830 - $324,510
-34,596 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$5.53 - $11.36 $191,315 - $393,010
34,596 New
34,596 $308,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IDERA PHARMACEUTICALS, INC.

IDRA Quotes by TradingView
  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email